Skip to main content
Erschienen in: Abdominal Radiology 1/2018

04.08.2017 | Invited article

Management implications and outcomes of LI-RADS-2, -3, -4, and -M category observations

verfasst von: Donald G. Mitchell, Mustafa R. Bashir, Claude B. Sirlin

Erschienen in: Abdominal Radiology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

A radiologist issuing a LI-RADS category is, implicitly or explicitly, a member of a multidisciplinary team. If the definite diagnosis of a benign or malignant entity is not possible, categorizing the uncertainty as LR-2, -3, -4, or -M has important management implications. In this article, we discuss the range of options for management or further diagnostic testing and how a LR category may affect the choice between them. We then review recent published data regarding eventual diagnoses following assignment of a LR category.
Literatur
1.
Zurück zum Zitat Mitchell DG, Bruix J, Sherman M, et al. (2015) LI-RADS (liver imaging reporting and data system): summary, discussion, and consensus of the LI-RADS management working group and future directions. Hepatology 61(3):1056–1065CrossRefPubMed Mitchell DG, Bruix J, Sherman M, et al. (2015) LI-RADS (liver imaging reporting and data system): summary, discussion, and consensus of the LI-RADS management working group and future directions. Hepatology 61(3):1056–1065CrossRefPubMed
2.
Zurück zum Zitat Holland AE, Hecht EM, Hahn WY, et al. (2005) Importance of small (≤20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237(3):938–944CrossRefPubMed Holland AE, Hecht EM, Hahn WY, et al. (2005) Importance of small (≤20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237(3):938–944CrossRefPubMed
3.
Zurück zum Zitat Kanematsu M, Kondo H, Semelka RC, et al. (2003) Early-enhancing non-neoplastic lesions on gadolinium-enhanced MRI of the liver. Clin Radiol 58(10):778–786CrossRefPubMed Kanematsu M, Kondo H, Semelka RC, et al. (2003) Early-enhancing non-neoplastic lesions on gadolinium-enhanced MRI of the liver. Clin Radiol 58(10):778–786CrossRefPubMed
4.
Zurück zum Zitat Jeong YY, Mitchell DG, Hann HWL, et al. (2001) Hepatocellular carcinoma after systemic chemotherapy: gadolinium-enhanced mr measurement of necrosis by volume histogram. J Comput Assist Tomogr 25(4):624–628CrossRefPubMed Jeong YY, Mitchell DG, Hann HWL, et al. (2001) Hepatocellular carcinoma after systemic chemotherapy: gadolinium-enhanced mr measurement of necrosis by volume histogram. J Comput Assist Tomogr 25(4):624–628CrossRefPubMed
5.
6.
Zurück zum Zitat Poulose KP, Reba RC, Gilday DL, et al. (1970) Diagnosis of pulmonary embolism. A correlative study of the clinical, scan, and angiographic findings. Br Med J 3(5714):67–71CrossRefPubMedPubMedCentral Poulose KP, Reba RC, Gilday DL, et al. (1970) Diagnosis of pulmonary embolism. A correlative study of the clinical, scan, and angiographic findings. Br Med J 3(5714):67–71CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Petruzzi N, Mitchell D, Guglielmo F, et al. (2013) Hepatocellular carcinoma likelihood on MRI exams: evaluation of a standardized categorization system. Acad Radiol 20(6):694–698CrossRefPubMed Petruzzi N, Mitchell D, Guglielmo F, et al. (2013) Hepatocellular carcinoma likelihood on MRI exams: evaluation of a standardized categorization system. Acad Radiol 20(6):694–698CrossRefPubMed
8.
Zurück zum Zitat Tanabe M, Kanki A, Wolfson T, et al. (2016) Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging. Radiology 281(1):129–139CrossRefPubMed Tanabe M, Kanki A, Wolfson T, et al. (2016) Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging. Radiology 281(1):129–139CrossRefPubMed
9.
Zurück zum Zitat Mitchell DG, Saini S, Weinreb J, et al. (1994) Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 193(1):49–57CrossRefPubMed Mitchell DG, Saini S, Weinreb J, et al. (1994) Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 193(1):49–57CrossRefPubMed
10.
Zurück zum Zitat Darnell A, Forner A, Rimola J, et al. (2015) Liver imaging reporting and data system with MR imaging: evaluation in nodules 20 mm or Smaller detected in cirrhosis at screening US. Radiology 275(3):698–707CrossRefPubMed Darnell A, Forner A, Rimola J, et al. (2015) Liver imaging reporting and data system with MR imaging: evaluation in nodules 20 mm or Smaller detected in cirrhosis at screening US. Radiology 275(3):698–707CrossRefPubMed
11.
Zurück zum Zitat Choi JY, Cho HC, Sun M, et al. (2013) Indeterminate observations (liver imaging reporting and data system category 3) on MRI in the cirrhotic liver: fate and clinical implications. AJR 201(5):993–1001CrossRefPubMed Choi JY, Cho HC, Sun M, et al. (2013) Indeterminate observations (liver imaging reporting and data system category 3) on MRI in the cirrhotic liver: fate and clinical implications. AJR 201(5):993–1001CrossRefPubMed
12.
Zurück zum Zitat Burke LM, Sofue K, Alagiyawanna M, et al. (2016) Natural history of liver imaging reporting and data system category 4 nodules in MRI. Abdom Radiol (NY) 41(9):1758–1766CrossRef Burke LM, Sofue K, Alagiyawanna M, et al. (2016) Natural history of liver imaging reporting and data system category 4 nodules in MRI. Abdom Radiol (NY) 41(9):1758–1766CrossRef
13.
Zurück zum Zitat Choi SH, Byun JH, Kim SY, et al. (2016) Liver Imaging reporting and data system v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Invest Radiol 51(8):483–490CrossRefPubMed Choi SH, Byun JH, Kim SY, et al. (2016) Liver Imaging reporting and data system v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Invest Radiol 51(8):483–490CrossRefPubMed
14.
Zurück zum Zitat Sofue, K., Burke, L., Nilmini, V., et al. (2017) Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5. J Magn Reson Imaging. doi:10.1002/jmri.25627 Sofue, K., Burke, L., Nilmini, V., et al. (2017) Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5. J Magn Reson Imaging. doi:10.​1002/​jmri.​25627
Metadaten
Titel
Management implications and outcomes of LI-RADS-2, -3, -4, and -M category observations
verfasst von
Donald G. Mitchell
Mustafa R. Bashir
Claude B. Sirlin
Publikationsdatum
04.08.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 1/2018
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1251-z

Weitere Artikel der Ausgabe 1/2018

Abdominal Radiology 1/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.